• Psoralen photoproducts were identified in association with cataracts in a psoriatic patient several years after oral methoxsalen plus ultraviolet A light (PUVA) therapy. Patients should be required to wear adequate optical protection not only during PUVA therapy but 24 hours following ingestion of methoxsalen.
(Arch Dermatol 1985;121:1307-1308)
Woo TY, Wong RC, Wong JM, Anderson TF, Lerman S. Lenticular Psoralen Photoproducts and Cataracts of a PUVA-Treated Psoriatic Patient. Arch Dermatol. 1985;121(10):1307-1308. doi:10.1001/archderm.1985.01660100087021